Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


Mayne Pharma Ventures Pty Ltd Create: Alert

All | News | Filings
Date FiledTypeDescription
01/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2019 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Acquired 362,121 shares @ $0
12/19/2018 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Acquired 184,798 shares @ $0
12/19/2018 SC 13D/A Mayne Pharma Ventures Pty Ltd reports a 59.1% stake in HedgePath Pharmaceuticals, Inc.
11/05/2018 SC 13D/A Mayne Pharma Ventures Pty Ltd reports a 59% stake in HedgePath Pharmaceuticals, Inc.
07/06/2018 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Bought 2,318,841 convertible preferred @ $0
Bought 1,739,131 options to buy @ $0
07/06/2018 SC 13D/A Mayne Pharma Ventures Pty Ltd reports a 59.1% stake in HedgePath Pharmaceuticals, Inc.
02/12/2018 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Bought 600,000 shares @ $162660, valued at $97596M
01/11/2018 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Bought 3,478,261 convertible preferred @ $0
Bought 2,608,696 options to buy @ $0
01/11/2018 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/02/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/28/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
11/15/2016 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 4,750,569 shares @ $0
Exercised (in-or-at-the-money) 333 shares @ $0
Exercised (in-or-at-the-money) 4,860,000 shares @ $0
Exercised (in-or-at-the-money) 4,750,569 options to buy @ $0.0878, valued at $417.1k
Exercised (in-or-at-the-money) 333 options to buy @ $0.075, valued at $25
Exercised (in-or-at-the-money) 4,860,000 options to buy @ $0.12, valued at $583.2k
11/15/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
11/07/2016 SC 13D/A Mayne Pharma Ventures Pty Ltd reports a 59.3% stake in HedgePath Pharmaceuticals, Inc.
11/07/2016 4 Mayne Pharma Ventures Pty Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 5,500,000 shares @ $0
Exercised (in-or-at-the-money) 33,333,000 shares @ $0
Exercised (in-or-at-the-money) 5,500,000 options to buy @ $0.0878, valued at $482.9k
Exercised (in-or-at-the-money) 33,333,000 options to buy @ $0.075, valued at $2.5M
06/16/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
05/27/2016 4 Mayne Pharma Group Ltd (10% Owner) has filed a Form 4 on HedgePath Pharmaceuticals, Inc.
Txns: Granted 27,885,000 shares @ $0
Granted 28,364,236 options to buy @ $0.012, valued at $340.4k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy